| Revue: | Anais brasileiros de dermatologia |
| Base de datos: | PERIÓDICA |
| Número de sistema: | 000385693 |
| ISSN: | 0365-0596 |
| Autores: | Quaresma, Maria Victoria1 Bernardes-Filho, Fred1 Oliveira, Fernanda Brandao de1 Pockstaller, Mercedes Prates1 Dias, Maria Fernanda Reis Gavazzoni1 Azulay, David Rubem1 |
| Instituciones: | 1Santa Casa da Misericordia do Rio de Janeiro, Instituto de Dermatologia Professor Rubem David Azulay, Rio de Janeiro. Brasil |
| Año: | 2015 |
| Periodo: | May-Jun |
| Volumen: | 90 |
| Número: | 3 |
| Paginación: | 123-127 |
| País: | Brasil |
| Idioma: | Inglés |
| Tipo de documento: | Artículo |
| Enfoque: | Caso clínico, descriptivo |
| Resumen en inglés | Drug-induced lupus is a rare drug reaction featuring the same symptoms as idiopathic lupus erythematosus. Recently, with the introduction of new medicines in clinical practice, an increase in the number of illness-triggering implicated drugs has been reported, with special emphasis on anti-TNF-α drugs. In the up-to-date list, almost one hundred medications have been associated with the occurrence of drug-induced lupus. The authors present two case reports of the illness induced respectively by hydralazine and infliximab, addressing the clinical and laboratorial characteristics, diagnosis, and treatment |
| Disciplinas: | Medicina |
| Palabras clave: | Dermatología, Farmacología, Infliximab, Hidralazina, Efectos adversos, Lupus eritematoso cutáneo |
| Keyword: | Medicine, Dermatology, Pharmacology, Infliximab, Hydralazine, Adverse effects, Cutaneous lupus erythematosus |
| Texte intégral: | Texto completo (Ver HTML) |
